ciprofloxacin has been researched along with Liver Failure, Acute in 5 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Liver Failure, Acute: A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin is a fluorinated quinolone antibiotic with relatively low occurrence of adverse side effects." | 2.42 | Ciprofloxacin-induced acute liver injury: case report and review of literature. ( Mikuz, G; Propst, A; Stadlmann, S; Terracciano, L; Vogel, W; Zimpfer, A, 2004) |
| "Hepatic encephalopathy due to acute hepatic failure is diagnosed and detoxification of ammonia with lactulose is started." | 1.43 | [Acute liver failure after ingestion of ciprofloxacin]. ( Kaddu-Mulindwa, D; Lammert, F; Link, A; Maßmann, A, 2016) |
| "We report a case of fulminant hepatic failure associated with Salmonella paratyphi A infection, in a 29-year-old patient who was admitted to the intensive care unit (ICU) with fever of two days, headache and vomiting followed by behavioural changes and disorientation." | 1.33 | Fulminant hepatic failure caused by Salmonella paratyphi A infection. ( Alomary, IY; Kamha, AA; Khan, FY, 2006) |
| "Fulminant hepatic failure is an uncommon but life-threatening adverse reaction to antibiotic therapy." | 1.32 | Non-fatal acute liver injury possibly related to high-dose ciprofloxacin. ( Galle, PR; Goetz, M; Schwarting, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaddu-Mulindwa, D | 1 |
| Lammert, F | 1 |
| Maßmann, A | 1 |
| Link, A | 1 |
| Goetz, M | 1 |
| Galle, PR | 1 |
| Schwarting, A | 1 |
| Zimpfer, A | 1 |
| Propst, A | 1 |
| Mikuz, G | 1 |
| Vogel, W | 1 |
| Terracciano, L | 1 |
| Stadlmann, S | 1 |
| Khan, FY | 1 |
| Kamha, AA | 1 |
| Alomary, IY | 1 |
| Assy, N | 1 |
| Gefen, H | 1 |
| Schlesinger, S | 1 |
| Hussein, O | 1 |
1 review available for ciprofloxacin and Liver Failure, Acute
| Article | Year |
|---|---|
Ciprofloxacin-induced acute liver injury: case report and review of literature.
Topics: Adult; Anti-Infective Agents; Biopsy; Ciprofloxacin; Eosinophils; Humans; Liver; Liver Failure, Acut | 2004 |
4 other studies available for ciprofloxacin and Liver Failure, Acute
| Article | Year |
|---|---|
[Acute liver failure after ingestion of ciprofloxacin].
Topics: Adult; Brain; Ciprofloxacin; Female; Humans; Liver Failure, Acute; Young Adult | 2016 |
Non-fatal acute liver injury possibly related to high-dose ciprofloxacin.
Topics: Aged; Ciprofloxacin; Critical Care; Dose-Response Relationship, Drug; Drug Administration Schedule; | 2003 |
Fulminant hepatic failure caused by Salmonella paratyphi A infection.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Dexamethasone; Gluc | 2006 |
The beneficial effect of N-acetylcysteine and ciprofloxacin therapy on the outcome of ischemic fulminant hepatic failure.
Topics: Acetylcysteine; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Free Radical Scavengers | 2007 |